Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
rF1V-1018
United Therapeutics Europe Ltd
Plague, Pneumonic
1 trial -
rituximab
United Therapeutics Europe Ltd
Lymphoma
1 trial -
sublingual nitroglycerine
United Therapeutics Europe Ltd
COLIC
1 trial -
treprostinil dienthanolmine sustained release
United Therapeutics Europe Ltd
Critical Limb Ischemia
1 trial -
treprostinil diethanolamine
United Therapeutics Europe Ltd
Systemic Sclerosis
2 trials -
trihexyphenidyl
United Therapeutics Europe Ltd
Dystonia
1 trial -
zinc supplementation
United Therapeutics Europe Ltd
HIV Infections
1 trial -
18F-PEG6-IPQA
United Therapeutics Europe Ltd
Lung Cancer
1 trial -
3-dimensional conformal radiation therapy
United Therapeutics Europe Ltd
Bladder Cancer
1 trial -
89Zr-DFO-YS5
United Therapeutics Europe Ltd
Prostate Cancer
1 trial -
ARN-75039 oral capsules
United Therapeutics Europe Ltd
Healthy Adult Participants
1 trial -
ASTX660
United Therapeutics Europe Ltd
Advanced Cancer
1 trial -
ATRA
United Therapeutics Europe Ltd
Pancreatic Adenocarcinoma
1 trial -
AZD2014 3 on/4 off & weekly paclitaxel
United Therapeutics Europe Ltd
Advanced Cancer
1 trial -
Acceptance and Commitment Therapy
United Therapeutics Europe Ltd
Stroke
1 trial -
Administration of UI087
United Therapeutics Europe Ltd
Diabetes Mellitus (Type 2)
1 trial -
Adoptive Cell Therapy with Tumor-infiltrating Lymphocytes (TIL)
United Therapeutics Europe Ltd
Urothelial Carcinoma
1 trial -
Allogeneic (MSC's) Application to the Burn Wounds
United Therapeutics Europe Ltd
Skin Burn Degree Second
1 trial -
Allogeneic MSC
United Therapeutics Europe Ltd
Mesenchymal Stromal Cells
1 trial -
Anplag
United Therapeutics Europe Ltd
Healthy
1 trial -
Anti CS6 BSIgG product (Lot PD1601105CS)
United Therapeutics Europe Ltd
Healthy Volunteer
1 trial -
Antibody UB-421
United Therapeutics Europe Ltd
HIV-1 Infection in Adults (Asymptomatic)
1 trial -
Arm B: A combination of pentoxifylline and tocopherol acetate in addition to best standard care [a structured programme of rehabilitation exercises] for 6 months
United Therapeutics Europe Ltd
Head and Neck Fibrosis
1 trial -
Atovaquone Oral Suspension
United Therapeutics Europe Ltd
Locally Advanced Non-Small Cell Lung Cancer
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources